Back to TCRX
BlackRock, Inc. TCRX Position History
TScan Therapeutics, Inc. • Healthcare
Quarters held
19
Latest value
$134K
Q3 2026
Peak value
$1M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $42K |
| Q4 2025 | $1M |
| Q4 2025 | $109K |
| Q4 2025 | $428K |
| Q4 2025 | $245K |
| Q4 2025 | $8K |
| Q1 2026 | $42K |
| Q1 2026 | $1M |
| Q1 2026 | $116K |
| Q1 2026 | $431K |
| Q1 2026 | $248K |
| Q2 2026 | $11K |
| Q2 2026 | $260K |
| Q2 2026 | $164K |
| Q2 2026 | $418K |
| Q2 2026 | $121K |
| Q3 2026 | $4K |
| Q3 2026 | $50K |
| Q3 2026 | $134K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $134K | 426.8K | — | — |
| Q3 2026 | $50K | 159.8K | — | — |
| Q3 2026 | $4K | 11.3K | — | — |
| Q2 2026 | $121K | 123.5K | — | — |
| Q2 2026 | $418K | 426.8K | — | — |
| Q2 2026 | $164K | 167.5K | — | — |
| Q2 2026 | $260K | 265.6K | — | — |
| Q2 2026 | $11K | 11.3K | — | — |
| Q1 2026 | $248K | 245.3K | — | — |
| Q1 2026 | $431K | 426.8K | — | — |
| Q1 2026 | $116K | 115.3K | — | — |
| Q1 2026 | $1M | 1.01M | — | — |
| Q1 2026 | $42K | 41.7K | — | — |
| Q4 2025 | $8K | 8.4K | — | — |
| Q4 2025 | $245K | 245.3K | — | — |
| Q4 2025 | $428K | 427.8K | — | — |
| Q4 2025 | $109K | 108.7K | — | — |
| Q4 2025 | $1M | 1.02M | — | — |
| Q4 2025 | $42K | 42.4K | — | — |
Other funds holding TCRX
$630M
$630M
$617.5M
$198.1M
$10.9M